A distinctive feature of malignant tumors in children is that they develop as a result of a genetic defect present from birth. When it manifests depends on the individual characteristics of the child's body. Malignant tumors first appear during age-related changes in the immune and endocrine systems, as well as during periods of active tissue growth. These are ages 1–5 and 11–14. Depending on the age period and the structural features of the tumor, the following are distinguished:
Embryonal tumors: Develop as a result of atypical cells resembling fetal tissue appearing in a location that is not typical for them.
Juvenile tumors: Occur in adolescence as a result of the transformation of mature cells. During this period, the body undergoes hormonal changes and active growth.
Adult-type tumors; These are extremely rare. In children, they do not differ from similar neoplasms in adults.
Oncological diseases in children have their own specific features. For example, it is known that cancers in children, unlike in adults, are exceptional cases and occur extremely rarely. The overall incidence of malignant tumors in children is relatively low, approximately 1-2 cases per 10000 children, while in adults this figure is dozens of times higher.
Different malignant diseases predominate in children depending on their age. In children under 6, hemoblastoses (blood malignancies), neuroblastoma and nephroblastoma are more common. In adolescents and children aged 11–12, tumors of the central nervous system and the musculoskeletal system are detected more often.
Atypical cells develop from blood and lymph precursor cells. This group includes leukemias, Hodgkin lymphoma (lymphogranulomatosis) and non-Hodgkin lymphomas. Leukemias rank first among childhood cancers. The acute form is detected more often; chronic leukemia is typical of adults. The vast majority of leukemias are lymphoblastic, with myeloblastic leukemias in second place. Undifferentiated cell leukemia is diagnosed very rarely.
The malignant process is located in the brain. These tumors appear mainly in adolescence and are classified as juvenile. CNS tumors include astrocytoma and ependymoma. The neoplasms are benign. When small, they cause no symptoms. When large, they disrupt the blood supply to the brain and the flow of cerebrospinal fluid. This manifests as changes in brain function, including mental activity.
The tumor is detected in children aged 1–5 and affects one, or less often both, kidneys. Often the only sign is abdominal asymmetry and a small lump found on palpation. With timely treatment, 80% of children recover completely.
This malignant tumor develops from the sympathetic nerves of the retroperitoneal space, mediastinum, neck or lumbosacral region. 75% of patients are children under 4. The neoplasm is classified as embryonal.
Atypical cells grow from bone tissue. It is a highly malignant neoplasm with an unfavorable prognosis. However, with the introduction of a new treatment method, the survival rate of children has increased from 28% to 43%. Osteosarcoma accounts for 10% of all childhood tumors.
It also grows in bone tissue. The atypical cells of this tumor are more sensitive to radiation, so the survival rate is somewhat higher than with osteosarcoma — up to 65%. Ewing sarcoma and osteosarcoma are juvenile tumors and are more common in adolescent boys.
These tumors grow from soft tissue cells, usually muscle elements, and can be located in the neck, in the reproductive organs, and less often in the trunk, limbs and orbit. The neoplasms do not metastasize for a long time, but they have infiltrative growth, i.e. they grow through the entire organ and adjacent tissues.
A malignant tumor of the retina that develops from embryonic cells. The peak incidence is at 2 years of age. Familial cases are typical.
Malignant neoplasms of other organs are rare in children and are usually similar to the corresponding tumors in adults. The clinical presentation of cancer in children has a number of specific features.
A malignant disease of the hematopoietic system. Initially, the tumor tissue is located in the bone marrow, which is responsible for producing blood cells. If a mutation occurs during the development of a blood cell, it becomes cancerous, loses the ability to perform its functions and gradually displaces healthy stem cells. The main distinguishing features of tumor cells are their ability to divide uncontrollably and to invade lymph nodes, the spleen, liver and other organs, causing pathological changes in them.